Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Single Arm Open Label Study for the Efficacy and Safety of Prolia in Treatment of Male Subjects With Osteoporosis in Mainland China

NCT06332014 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT06332014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06332014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Single Arm Open Label Study for the Efficacy and Safety of Prolia in Treatment of Male Subjects With Osteoporosis in Mainland China
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 6, 2024
Completion date
January 23, 2027
Enrollment
102 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis